Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:14 AM
Ignite Modification Date:
2025-12-26 @ 11:14 AM
NCT ID:
NCT04734028
Eligibility Criteria:
Inclusion Criteria:
* Consecutive patients at every centre successfully treated with one or more DES approved by the US FDA or CE mark and who were adequately loaded with clopidogrel were eligible for enrolment, regardless of patient or lesion complexity.
Exclusion Criteria:
* the occurrence of a major complication during the procedure or before platelet function testing, or if bypass surgery was planned after PCI.
* Any P2Y12 inhibitor other than clopidogrel
* PCI strategy other than DES
* Needed oral anticoagulant (e.g. atrial fibrillation)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04734028
Study Brief:
Protocol Section:
NCT04734028